NCT03027986

Brief Summary

Urinary incontinence (UI) is defined by the International Continence Society as "any involuntary loss of urine complained by the patient". The anatomical and histological specificities of the pelvic floor muscles (PFM) give them a key role in the control of urination but also in the control of postural stability. These activities are involuntary automatisms and the mechanisms that lead to post-prostatectomy stress urinary incontinence are not only due to the loss of voluntary contraction of the pelvic floor muscles. The mechanisms that lead to UI are more complex and may involve the loss of efficacy of all deep muscle stabilizing lumbo-pelvic region. Rehabilitation of pelvic floor muscles is recommended in the treatment of urinary incontinence after prostatectomy (Grade A), but there is a lack of evidence to define the best treatment regimen for PFM rehabilitation. Two kinds of PFM rehabilitation are are commonly practiced by specialized physiotherapists.

  • The first one is made in individual box, in supine position. By analytic contractions of the PFM, (exercises of Kegel type) +/- associated with an instrumental biofeedback. This method used voluntary contractions of MPP.
  • The second is realized in various positions following a gravity progression, in individual and /or common room. This technique aims to restore a stabilization of the entire lumbo-pelvic region by postural recruitment involving synergistic contractions of the PFM. These trials propose to compare these two rehabilitation programs on populations with postoperative follow-up of more than 12 months. We chose to objectify the urine leaks with the pad test (weighing of the protections urinary over a period of 3 times 24h) which will be our main evaluation criterion. The home test pad of 3 times in 24 hours has been used by numerous studies and its reproducibility and reliability are established. Urinary incontinence is a recognized factor of sedentary lifestyle, fatigue, impaired mental health and decreased of physical fitness. We therefore wish to observe these parameters for each of our two randomized groups

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 19, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 23, 2017

Completed
8 months until next milestone

Study Start

First participant enrolled

October 2, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 14, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 14, 2019

Completed
Last Updated

February 17, 2026

Status Verified

May 1, 2018

Enrollment Period

2 years

First QC Date

January 19, 2017

Last Update Submit

February 13, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference from baseline in urine leakage

    urine leakage will be measured using pad test

    6 months

Secondary Outcomes (2)

  • Difference from baseline in The Berg balance scale test

    6 months

  • Difference from baseline in quality of life

    6 months

Study Arms (2)

postural rehabilitation program based on sensory-motor control

EXPERIMENTAL
Behavioral: postural rehabilitation program

Standard physiotherapy

NO INTERVENTION

Interventions

This program is based on sensory-motor control

postural rehabilitation program based on sensory-motor control

Eligibility Criteria

Age18 Years - 78 Years
Sexmale(Gender-based eligibility)
Gender Eligibility Detailsthis medical condition for participation is patient with a prostatectomy
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Gender: Male
  • Between the age of 18 and 78 years
  • Patient who underwent prostatectomy more than 12 months ago but less than 10 years
  • x24h pad test over or equivalent to 10 grs
  • Persistent urinary incontinence beyond 12 month following prostatectomy
  • Patient affiliated to social security
  • Patient who submitted non-opposition for participation in the study

You may not qualify if:

  • Patients who underwent prostatectomy or other visceral surgery less than one year ago
  • Patient who underwent surgical treatment of urinary incontinence
  • Patient with urinary incontinence less than 10g
  • Radio, hormone, or chemotherapy cured or in progress
  • Anticholinergic treatment less than 3 months ago
  • Patient with neurological or bladder disorders potentially involved in incontinence disorders
  • Vestibular or psychiatric pathology making limitations to carry out all the examinations provided for in the protocol
  • Patient unable to complete the planned 15 visits to physiotherapist
  • Patient participating in another clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rouen University Hospital

Rouen, France

Location

MeSH Terms

Conditions

Urinary IncontinenceProstatic Neoplasms

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsGenital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesProstatic Diseases

Study Officials

  • Benoît STEENSTRUP

    University Hospital, Rouen

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2017

First Posted

January 23, 2017

Study Start

October 2, 2017

Primary Completion

October 14, 2019

Study Completion

October 14, 2019

Last Updated

February 17, 2026

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Locations